New drug duo takes on amlodipine in blood pressure battle for heavier patients
NCT ID NCT07241338
First seen Nov 21, 2025 · Last updated May 06, 2026 · Updated 19 times
Summary
This study compares a new combination drug (sacubitril/allisartan) with a standard medicine (amlodipine) to see which lowers blood pressure better in overweight or obese adults. About 104 participants aged 18-75 with high blood pressure and a BMI of 24 or higher will be randomly assigned to one of the two treatments. The main goal is to measure changes in sitting systolic blood pressure after 8 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University People's Hospital
Beijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.